33 search results for: COPD

Infographic

Eosinophils: A Biomarker in COPD

5 min

Pulmonology

Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.

videoanimation

GOLD Diagnosis and Assessment of COPD

10 min

Pulmonology

This short video presentation outlines the diagnosis and assessment of COPD according to the GOLD report, focusing on clinical features and assessment goals.

The Heterogeneity of Underlying Inflammation in Patients With <b>COPD</b>

expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

2 min

Pulmonology

Join global expert Professor Ian Pavord as he discusses the heterogeneity of underlying inflammation in patients with COPD.

Uncovering the Impact of Moderate <b>COPD</b> Exacerbations

interactivity

Uncovering the Impact of Moderate COPD Exacerbations

5 min

Pulmonology

Understand the impact of moderate chronic obstructive pulmonary disease (COPD) exacerbations on future exacerbation risk, lung function decline, mortality, and patient quality of life.

What Differentiates <b>COPD</b> Exacerbations From Asthma Exacerbations?

expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

2 min

Pulmonology

Join global expert Dr. Eric Bateman as he discusses how exacerbations in patients with COPD are different than exacerbations in patients with asthma.

expert video

Impact of Exacerbations in COPD

2 min

Type 2 Inflammation

Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality

expert video

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

35 min

Pulmonology

Professors Klaus Rabe, Paola Rogliani, and Dr. Stephanie Christenson explore the complexity of inflammatory pathways and phenotypes in COPD. They provide insights into the genetic association of IL-33 with COPD, and discuss preclinical findings.

ERS 2024 | Living With <b>COPD</b>: Linking Inflammation with Patient Burden

expert video

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden

14 min

Pulmonology

Professor Henrik Watz explores the complex relationship between inflammation and COPD, highlighting its impact on patients' health and overall quality of life.

expert video

What Is The COPD Vicious Cycle?

3 min

Pulmonology

Dr. Nicola Hanania explains the vicious cycle of exacerbations and lung function decline observed in COPD.

ERS 2024 | Understanding the Complex Pathophysiology of <b>COPD</b>

expert video

ERS 2024 | Understanding the Complex Pathophysiology of COPD

6 min

Pulmonology

Professor Klaus Rabe delves into the intricate inflammatory pathways and cellular mechanisms that drive the development and progression of COPD.

ERS 2024 | Unraveling the Role of Type 2 Inflammation in <b>COPD</b>

expert video

ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD

8 min

Pulmonology

Professor Mona Bafadhel presents a comprehensive overview of type 2 inflammation in COPD, exploring its underlying mechanisms, clinical manifestations, and implications for patient outcomes.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region